XML 49 R36.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value Measurements (Cont Liab and Debt) (Details) - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2014
Dec. 31, 2015
Jun. 23, 2014
Apr. 14, 2014
Additional fair value disclosures        
Interest rate (as a percent)   8.00%    
Debt outstanding   $ 43,750,000    
8.00% Convertible Senior Notes Due 2019        
Additional fair value disclosures        
Aggregate principal amount $ 47,000,000 $ 43,750,000 $ 47,000,000  
Interest rate (as a percent)   8.00% 8.00%  
Debt outstanding   $ 43,750,000    
Period from conversion date considered for interest make-whole payment 3 years 3 years    
Shape Pharmaceuticals        
Additional fair value disclosures        
Percentage of share capital acquired       100.00%
Low end of range of undiscounted amounts       $ 0
High end of range of undiscounted amounts       $ 64,500,000